Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

SBL Final > Cancer Pharmacology (Part 1 of 2) > Flashcards

Cancer Pharmacology (Part 1 of 2) Flashcards

1
Q

What are oncogenes?

A

genes that positively influence tumor formation/ cell growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is an example of an oncogene?

A

Ras

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a tumor suppressor gene?

A

genes that negatively impact tumor growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is an example of a tumor suppressor gene?

A

p53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how would you know whether a gene is an oncogene or a tumor suppressor?

A

oncogenes promote cell growth while tumor suppressor genes slow growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the majority of cells in our bodies are at what phase of the cell cycle?

A

G0 “resting”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the purpose of cell cycle checkpoints?

A

they control transitions between cell cycle stages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is being checked at cell cycle checkpoints?

A

is there DNA damage? is there spindle assembly? are there favorable conditions? is there completed replication?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what happens if there is failure to pass a cell cycle checkpoint?

A

the cell cycle is delayed or cell apoptose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

aberrations in checkpoint regulation result in what?

A

uncontrolled and unregulated cell proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

activation of oncogenes has what result?

A

it overrides G1 arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

inactivation of tumor suppressor genes has what result?

A

overrides G2 arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the indications for primary chemotherapy?

A

when the cancer is advanced, no alternative treatment exists, or it is an advanced metastatic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

primary chemotherapy can cure some cancers- what are they?

A

hodgkin’s and non-hodgkin’s lymphoma, choriocarcinoma, germ cell cancer, and AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is neoadjuvant chemotherapy?

A

the use of chemotherapy in patients who present with localized cancer for which alternative local therapies, such as surgery, exist, but which have been shown to be less than completely effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the goal of neoadjuvant chemotherapy?

A

to reduce the size of the primary tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is adjuvant chemotherapy?

A

when additional chemotherapy is given for a defined period of time after surgery–> helps to prevent relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the goals of adjuvant chemotherapy?

A

to reduce the incidence of local and systemic recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is tissue growth fraction?

A

the ratio of proliferating to G0 cells

20
Q

as a general rule, antineoplastic agents are more effective on?

A

cells with a high growth fraction; and they will impact noncancerous high growth cells

21
Q

what are some examples of cells with high growth fraction?

A

cells of the bone marrow, GI tract, hair follicles, and sperm-forming cells

22
Q

what is one significant determinant of responsiveness to chemotherapy?

A

the growth fraction

23
Q

as the tumor burden increases, what happens to the growth fraction and the doubling time?

A

the growth fraction decreases and the doubling time increases

24
Q

the initial growth rate of most solid tumors is what?

A

rapid but decreases over time

25
Q

why is a low growth fraction in tumors challenging?

A

because chemotherapy will have minor activity

26
Q

the growth fraction of solid tumors can be increased how?

A

by reducing the tumor burden (i.e. surgery or radiation)

27
Q

what does the log cell kill hypothesis allow us to better understand?

A

the impact of the effect that a single dose has on the cancer cells: it’s a fraction of cells rather than an absolute number- so in each individual treatment, you can expect to kill a fraction of the cells that are remaining

28
Q

antineoplastic therapy follows what kinetics? and what does this mean?

A

first-order; this means that a given dose of drug destroys a constant fraction of cells

29
Q

what is the approach to the eradication of cancer like?

A

it is a step-wise approach

30
Q

what are common routes of administration of antineoplastic drugs?

A

IV and PO

31
Q

what are the benefits of alternative routes of administration of antineoplastic drugs?

A

they can reduce systemic toxicity and increase drug delivery (by avoiding pharmacologic sanctuaries)

32
Q

what are pharmacological sanctuaries?

A

regions where tumor cells are less susceptive to antineoplastic agents

33
Q

what are some examples of alternative routes of administration of antineoplastic drugs?

A

intracavity, intrathecal, intraventricular, intraarterial, topical, and isolated limb perfusion

34
Q

combination drug therapy is more successful than single-agent regimens; what are the advantages of combination chemotherapy?

A

it provides maximal cell killing within the range of tolerated toxicity; it is effective against a broader range of cell lines in a heterogenous tumor population and it may delay or prevent the development of drug-resistant tumors

35
Q

what is primary/inherent chemotherapeutic resistance?

A

drug resistance in the absence of prior exposure to available standard agents

36
Q

what is the main contributor to primary/inherent chemotherapeutic resistance?

A

the genomic instability (i.e. p53 mutations)

37
Q

what is acquired chemotherapeutic drug resistance?

A

develops in response to exposure to a given cancer chemotherapeutic drug

38
Q

what genetic change is occurring in cases of acquired chemotherapeutic drug resistance?

A

amplification or suppression of a particular gene

39
Q

how does the increasing heterogeneity of cancers over time affect treatment plan?

A

as the different cell lineages within the cancer cell changes, it affects our ability to kill and target those cancers

40
Q

what is p-glycoprotein (PGP) and where is it expressed?

A

it is expressed in tissues with barrier functions, such as the kidneys, liver, and GI tract; it does a really good job of taking drugs that are inside the cell and kicking them out

41
Q

what does a high baseline expression of PGP correlate with?

A

correlates with primary/inherent resistance to natural products; PGP can also be over-expressed leading to acquired drug resistance

42
Q

many antineoplastic agents are mutagens themselves- what does this mean? and give an example

A

they can give rise to neoplasms years after treatment (e.g. alkylating agents have cause AML and ALL)

43
Q

what are common adverse effects of antineoplastic agents?

A

nausea, vomiting, fatigue, stomatitis, and alopecia; myelosuppression, low sperm count, and depressed development of exposed children

44
Q

what can myelosuppression lead to?

A

can lead to impaired wound healing and predisposition to infection

45
Q

what agents are used as rescue agents for neutropenia, thrombocytopenia, and anemia?

A

hematopoietic agents

46
Q

what agents are used as rescue agents for emetogenic effects?

A

serotonin receptor antagonist (ondansetron)

47
Q

what agents are used as rescue agents to delay skeletal complications?

A

bisphosphonates

SBL Final (21 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions